GMED - Globus Medical, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
769,639
712,969
635,977
563,994
Cost of Revenue
177,168
159,410
150,453
134,705
Gross Profit
592,471
553,559
485,524
429,289
Operating Expenses
Research Development
58,335
55,496
43,679
44,532
Selling General and Administrative
346,260
311,591
267,817
222,156
Total Operating Expenses
425,573
382,553
322,073
273,322
Operating Income or Loss
166,898
171,006
163,451
155,967
Interest Expense
-
-
-
-
Total Other Income/Expenses Net
-892
17,599
6,477
1,312
Income Before Tax
183,124
188,605
169,928
157,279
Income Tax Expense
36,693
32,131
62,580
52,938
Income from Continuing Operations
146,431
156,474
107,348
104,341
Net Income
146,431
156,474
107,348
104,341
Net Income available to common shareholders
146,431
156,474
107,348
104,341
Reported EPS
Basic
-
1.60
1.12
1.09
Diluted
-
1.54
1.10
1.08
Weighted average shares outstanding
Basic
-
97,884
96,243
95,647
Diluted
-
101,316
97,887
96,432
EBITDA
-
212,636
205,518
194,738